MAKO Surgical Corp.
Mark Distin has a strong background in sales and market development within the medical industry. At MAKO Surgical Corp., Mark serves as the Market Development Manager, where responsibilities likely include overseeing market strategies and initiatives. Prior to this role, Mark held the position of Director of Sales at OMNI life science, Inc. from 2004 to 2007, and also served as Director of Sales at PLUS Orthopaedics from 2001 to 2004, demonstrating a consistent track record of leadership and sales expertise in the orthopedic sector.
This person is not in any offices
MAKO Surgical Corp.
1 followers
MAKO Surgical Corp. is a medical device company that markets its advanced robotic solution and implants for minimally invasive orthopedic knee procedures. The RIO® Robotic Arm Interactive Orthopedic System includes a platform that utilizes tactile-resistance and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive robotic arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty ® to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritis knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants.